NCT06351085Recruiting
Enhancing Lung Cancer Screening Through Human-Centered Intervention
University of California, DavisClinicalTrials.govbehavioral
Study focus
- Disease/Condition
- Lung Cancer
- Drug/Device/Intervention
- Pre-Visit Planner
- Study type
- Interventional
- Intervention type
- behavioral
Sponsor & location
- Primary sponsor
- University of California, Davis
- Location
- Sacramento, United States of America
Timeline & enrollment
- Phase
- N/A
- Start date
- Nov 10, 2022
- End date
- Apr 14, 2025
- Enrollment
- 2869 participants
Primary outcome
Lung Cancer Screening
Summary
The purpose of this study is to further understand the factors involved in increasing lung
 cancer screening.
ICD-10 classifications
Carcinoma in situ: Bronchus and lungSecondary malignant neoplasm of lungMalignant neoplasm of bronchus and lungMalignant neoplasm: Bronchus or lung, unspecifiedMalignant neoplasm: Overlapping lesion of bronchus and lung
Data source
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06351085
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for NCT06351085 through Pure Global AI's free database. This phase not specified trial is sponsored by University of California, Davis and is currently Recruiting. The study focuses on Lung Cancer. Target enrollment is 2869 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.